LNA Santé S.A.
LNA.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €446 | €417 | €390 | €372 |
| % Growth | 7.1% | 7% | 4.6% | – |
| Cost of Goods Sold | €383 | €291 | €260 | €254 |
| Gross Profit | €63 | €89 | €130 | €119 |
| % Margin | 14.1% | 21.3% | 33.3% | 31.9% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €18 | €1 | €46 | €35 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €19 | €96 | €51 | €53 |
| Operating Expenses | €36 | €97 | €97 | €87 |
| Operating Income | €27 | €84 | €24 | €31 |
| % Margin | 6% | 20.1% | 6.1% | 8.4% |
| Other Income/Exp. Net | -€9 | -€14 | -€5 | -€13 |
| Pre-Tax Income | €18 | €15 | €19 | €19 |
| Tax Expense | €6 | €5 | €6 | €7 |
| Net Income | €11 | €9 | €12 | €11 |
| % Margin | 2.5% | 2.3% | 3.2% | 3.1% |
| EPS | 1.1 | 0.83 | 1.21 | 1.12 |
| % Growth | 32.5% | -31.4% | 8% | – |
| EPS Diluted | 1.1 | 0.83 | 1.21 | 1.12 |
| Weighted Avg Shares Out | 10 | 11 | 10 | 10 |
| Weighted Avg Shares Out Dil | 10 | 11 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €15 | €15 | €14 | €14 |
| Depreciation & Amortization | €42 | €17 | €11 | €11 |
| EBITDA | €75 | €65 | €44 | €43 |
| % Margin | 16.8% | 15.6% | 11.4% | 11.4% |